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Abstract: Copolymers of 2-dimethyl(aminoethyl) methacrylate (PDMAEM) with N-isopro-
pylacrylamide (NIPAM) were evaluated for their potential to enhance transgene expression 
of plasmid DNA (pDNA) and gene delivery by adenovirus vectors. The polymers of varying 
compositions and molecular weights (MW) were synthesized by free-radical polymerization. 
Polyelectrolyte complexes (PECs) were prepared with different charge (N:P) ratios of PNIPAM/
DMAEM to pDNA. Polymer-modiﬁ  ed viral vectors based on non-replicating adenovirus serotype 
5 (Ad5), (ΔE1/oriP/luc) or (ΔE1/CMV/luc) transcriptor/promoter/reporter were constructed by 
electrostatically coupling PNIPAM/DMAEM (Type I) or PECs (oriP/luc, 6.6 kb) (Type II) to the 
viral capsid. The N:P value at complete condensation was lower for PECs with higher DMAEM 
content and MW. pDNA binding was enhanced by high MW PNIPAM/DMAEM. Circular dichro-
ism spectroscopy revealed changes to the secondary structure of pDNA and adenovirus capsid 
proteins in the presence of PNIPAM/DMAEM. The toxicity of PNIPAM/DMAEM to CNE-1 
nasopharyngeal cancer (NPC) cells diminished with decreasing DMAEM content and increasing 
MW. The transfection efﬁ  ciency of C666-1 NPC cells by PECs increased with DMAEM content 
and MW. The transduction efﬁ  ciency of CNE-1 NPC cells by Type I Ad5 vectors improved 
with DMAEM content, but was independent of MW. The transduction efﬁ  ciency of Type II 
Ad5 in C666-1 cells approximated the sum of expression levels of the PECs and Ad5 vectors 
individually. PDMAEM and PNIPAM/DMAEM demonstrate both transfection and transduction 
enhancement activity of modiﬁ  ed vectors in nasopharyngeal cancer cells in culture.
Keywords: polymers of 2-dimethyl(aminoethyl) methacrylate and N-isopropylacrylamide, 
polymer-DNA complex, polymer-modiﬁ  ed adenovirus, cytotoxicity, transduction efﬁ  ciency
Introduction
In cancer gene therapy, a major factor impeding the therapeutic efﬁ  cacy of both 
non-viral and viral vectors is the inability of the vector to achieve directed expres-
sion by localizing at the site of action and effecting gene transfer selectively in the 
neoplastic cells (Yu and Schaffer 2005; Glasgow et al 2006; Pirollo et al 2000, 2006). 
Non-viral vectors such as polyelectrolyte complexes (PECs) prepared by condensing 
plasmid DNA with polycations such as lipids (Ewert et al 2005), poly-L-lysine (PLL) 
(Ramsay and Gumbleton 2002; Conswell and Huang 2005) and polyethyleneimine 
(PEI) (Boussif et al 1995; Woodle et al 2001) are hampered by the requirement of 
a suitable ligand or antibody directed towards a speciﬁ  c cancer cell receptor target. 
Viral vectors such as adenovirus serotype 2 and serotype 5 (Ad2 and Ad5) have been 
extensively investigated for cancer gene therapy due to their engineering potential, but 
are hampered by reticuloendothelial system (RES) clearance, immunogenicity, and International Journal of Nanomedicine 2007:2(3) 462
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difﬁ  culty controlling the site of viral uptake and expression 
due to the paucity of expression of the coxsackie adenovirus 
receptor (CAR) in a variety of malignant cell types (Volpers 
and Kochanek 2004; Noureddini and Curiel 2005; Shinozaki 
et al 2006). Attempts to divert adenovirus away from the 
liver and non-diseased tissues by ablation of the CAR and 
integrin receptor binding functions of the ﬁ  ber knob and 
penton bases, restricts the targeting potential to speciﬁ  c 
cells and is fraught with technical challenges (Wickham 
et al 1996; Bilbao et al 1998; Alemany et al 2000; Wickam 
2000). Other approaches have sought to exploit adenovirus 
promiscuity, opting instead to target at the level of ex-
pression by restricting viral genome transcription to cells 
possessing appropriate transcriptional activating markers 
(Douglas and Curiel 1997; Kirn 2001).
A potentially unifying approach for targeting non-viral 
and viral vectors involves coupling of polymers that undergo 
changes in biophysical properties selectively in tumor tis-
sues. By sensing (sensor function) and responding (effector 
function) to environmental stimuli such as temperature, pH 
or ionic strength, selective locoregional accumulation of re-
sponsive polymer coupled vectors may circumvent the need 
for speciﬁ  c cellular targets following systemic administration 
(Kurisawa et al 2000; Takeda et al 2004; Twaites et al 2004, 
2005). Surface modiﬁ  cation strategies of the adenovirus cap-
sid have been extensively used to target poly(ethylene glycol) 
(PEG)-coupled so called “stealth” adenovirus vectors bearing 
target cell speciﬁ  c ligands (Torchilin 1996; O’Riordan et al 
1999; Croyle et al 2001). These vectors have shown some 
improvements in reducing liver clearance and masking capsid 
protein immunogenicity, while increasing circulation time 
and improving the potential for perivascular escape (Romanc-
zuk et al 1995; Chillon et al 1998; Woodle et al 2001; Croyle 
et al 2002; Eto et al 2004; Mok et al 2005). Alternatively, 
polycation coating of the adenovirus capsid to generate poly-
cation-adenovirus complexes bearing PEI, PLL or various 
cationic lipid surfaces have demonstrated the potential to 
enhance transgene expression in CAR deﬁ  cient cell lines and 
reduce immunogenic response associated with high vector 
doses (Fasbender et al 1997; Kaplan et al 1998; Diebold et al 
1999; Nicola et al 2000). The principal mechanism by which 
polycations promote adenovirus transduction is thought to 
involve electrostatic interaction of cationic polymer seg-
ments with the cell membrane. Once in close proximity, cell 
membrane destabilization by the cationic polymer segments 
may exacerbate the action of viral proteins used for cell 
entry, effectively promoting cellular uptake of the vector 
(Wickam et al 1992).
In this work, we characterize potentially targetable 
non-viral PEC and polycation-adenovirus complex vectors 
that incorporate temperature- and pH-responsive polymer 
components, N-isopropylacrylamide (NIPAM) and 2-
dimethyl(aminoethyl) methacrylate (DMAEM) respectively. 
PolyNIPAM (PNIPAM) is a thermosensitive polymer with 
a lower critical solution temperature (LCST) near 32 ºC 
(Heskins and Guillet 1968; Schild 1992). The viability of 
this polymer in systemic delivery systems was suggested 
by our previous work that showed low levels of plasma 
protein adsorption and stimulation of phagocytic activity of 
human neutrophils by PNIPAM/methacrylic acid (MAA) 
nanoparticles due to their hydrophilic nature (Moselhy et al 
2000). PDMAEM is a cationic polymer at pH 7.4 that has 
been used extensively in non-viral vectors for gene delivery 
(Hinrichs et al 1999; Rungsardthong et al 2001; Wakebayashi 
et al 2004; Funhoff et al 2005). PDMAEM based PECs have 
been found to transfect a wide variety of cell types due to the 
ability of the polymer to condense pDNA, buffer lysosomal 
acidity, and transiently disrupt lipid bilayer membranes 
(Cheng et al 1999; Wetering et al 2000; Takeda et al 2004). 
PNIPAM/DMAEM PECs have been shown by Hinrichs et al. 
to effectively transfect the OVCAR-3 ovarian cancer cell 
line (Hinrichs et al 1999). Kurisawa et al. have advanced the 
functional role of NIPAM/DMAEM by utilizing terpolymers 
with butylmethacrylate (BMA) to effect thermally regulated 
expression of therapeutic genes (Kurisawa et al 2000). These 
studies illustrate the versatility of temperature responsive 
polymers for directed gene expression.
We envisage two classes of adenovirus complexes based 
on the adenovirus serotype 5 (Ad5) and NIPAM/DMAEM 
copolymers, Types I and II. These classes are distinguished 
on the basis of the vector component responsible for gene 
expression. Type I Ad5 vectors utilize solely viral regulated 
expression and they are prepared by complexing the polyca-
tions with Ad5 directly. Type II complexes acquire plasmid 
controlled gene expression via the complexation of the PECs 
(bearing transcriptionally active pDNA) electrostatically to 
the Ad5 capsid. Type II complexes by virtue of their tran-
scriptionally inactive viral genome, may be less likely to 
induce cell-mediated immune response than Type I vectors 
in which the viral genome remains intact (Baker et al 1997a, 
b). Both types of vectors have the potential to reduce immune 
response due to the shielding of the highly immunogenic ﬁ  ber 
knob and penton bases by the polycations, however only the 
Type I vectors retain the functional genetic elements that 
may be required for efﬁ  cient viral entry and gene expres-
sion in the cell.International Journal of Nanomedicine 2007:2(3) 463
Polymers and adenoviral vectors for gene delivery to cancer cells
The cancer gene therapy model investigated here is 
Ad5 gene delivery to nasopharyngeal carcinoma (NPC) 
cells in culture. NPC is an epithelial malignancy of the 
head and neck region for which survival outcome after 
treatment with radial radiation therapy (XRT) needs to be 
improved (Lee et al 2001). In vitro treatment of NPC cells 
by Ad5 vector expressing wild type p53 has been shown to 
promote their apoptosis when subjected to hyperthermia, 
either alone or in combination with XRT (Qi et al 2001). 
The NPC cells are highly transfectable by Ad5 suggesting 
that CAR expression is not a limiting factor (Hwang et al 
1998). In spite of this, in vivo studies in NPC xenograft 
models have demonstrated poor Ad5 vector performance, 
suggesting that rapid RES clearance might be an impor-
tant mitigating factor (Liu 2002). Since modification 
of nanoparticles by hydrophilic polymer could reduce 
RES recognition and uptake of the particles (Moselhy 
et al 2000), we investigated in this work hydrophilic 
polymer-modified Ad5 vectors to exploit the potential 
of such vectors to facilitate CAR-independent cell entry 
and a strategy for targeting leading to the development 
of improved gene therapies for NPC.
Materials and methods
Materials
N-isopropylacrylamide (NIPAM, 97%, Aldrich) was 
recrystallized from 70:30 hexane:toluene mixtures and 
dried in vacuo at room temperature. 2-(dimethylamino) 
ethyl methacrylate (DMAEM, Aldrich) was distilled 
under reduced pressure (45 ºC, 5 mmHg). 2,2′-azobi-
sisobuyronitrile (AIBN, Aldrich) was recrystallized from 
methanol and dried in vacuo. 1,4-dioxane (ACS grade, 
Fisher), 2-mercaptoethanol (Aldrich) and ethidium bro-
mide (Sigma) were used as received. Distilled deionized 
(DDI) water was prepared with a Millipore system and 
used for dilution purposes throughout.
Cells lines
The human nasopharyngeal cancer epithelial cell lines, 
CNE-1 and C666-1, used in this study have been described 
elsewhere (Cheung et al 1999; Li et al 2002). The CNE-1 cells 
were cultured in alpha minimum essential medium (α-MEM, 
Sigma) and C666-1 in RPMI-1640 (Sigma), respectively at 
37 ºC in a humidiﬁ  ed incubator containing 5% CO2. The 
media were supplemented with L-glutamine (200 mM), 
penicillin (10,000 units), streptomycin (10 mg in aqueous 
sodium chloride 0.9%, Sigma) and 10% Fetal Calf Serum 
(FCS, Wisent Inc.). The cells were passaged by trypsinizing 
nearly conﬂ  uent cells in T-75 ﬂ  asks at 1:6 dilution for CNE-1 
cells, and 1:3 dilution for C666-1 cells.
Synthesis and characterization 
of PNIPAM/DMAEM copolymers
To a Schlenk ﬂ  ask, DMAEM and NIPAM were added in the 
desired feed proportions to 100 mL of 1,4-dioxane (10%w/v 
monomers) and heated to 60 °C. For synthesis of polymers 
of low molecular weight, 2-mercaptoethanol was added as 
a chain transfer agent (CTA) at a 10:1 monomer/CTA molar 
ratio. The monomer mixture was allowed to thermally equili-
brate and degassed under nitrogen for 10 minutes, followed 
by rapid injection of 2 mL of free-radical initiator, AIBN, 
degassed at 60 °C, at a 100:1 monomer/initiator molar ratio. 
After polymerization for 12 h under nitrogen, the reaction 
mixture was cooled and the resultant polymers were collected 
by precipitation into hexane and dried in vacuo. The polymers 
were dissolved in DDI water and exhaustively dialyzed for 
72 h using a SpectraPor 3 membrane with molecular weight 
cut-off 3500.
The copolymer composition was determined by 1H NMR 
spectroscopy using Gemini 300 (Varian, Palo Alto, CA) in 
D2O at 300 MHz. The relative abundance of NIPAM and 
DMAEM in the copolymer samples was calculated from 
the ratio of the integrated area under the peaks correspond-
ing to proton resonances unique to the monomers, that is, 
δ = 3.9 ppm for NIPAM, 1H, s, CONHCH(CH3)2, and δ = 
4.4 ppm for DMAEM, 2H, t, COOCH2CH2N(CH3)2.
The intrinsic viscosity of polymers was determined from 
polymer solutions of concentrations ranging from 1 mg/mL 
to 5 mg/mL in 270 mmol/L KCl using a Cannon Ubbelohde 
#75 dilution type viscometer. The monovalent electrolyte 
was added to minimize electrostatic effects on the viscosity 
of polymer solutions. The average molecular weight of the 
polymers was determined using the Mark-Houwink (M-H) 
equation, η = KMa, where K and a values for the copolymers 
were computed from previously published data for NIPAM, 
KNIPAM = 5.75 × 10–5 and aNIPAM = 0.78, and for DMAEM, 
K = 9.13 × 10–4, respectively (Egoyan 1985; Ganachaud 
et al 2000), under the assumption of linear additivity of 
the parameters with respect to the copolymer composition 
determined by 1H NMR.
The pKa of the copolymers was determined by poten-
tiometric and conductometric coupled titration of 10 mg/
mL polymer solutions with 0.05 N NaOH at 25 °C using 
a Radiometer Copenhagen ABU-93 triburette autotitra-
tor mated to a Radiometer Copenhagen Model CDM92 
conductivity meter. The equivalent points in the titrations International Journal of Nanomedicine 2007:2(3) 464
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of polymer solutions we found from the inflection points 
of the titration curves. The pKa values were derived from 
the potentiometric data and represented the pH at one half 
the volume of base required to fully titrate tertiary amino 
groups on DMAEM. There was good agreement between 
pKa values derived potentiometrically and those obtained 
conductomerically.
Preparation and puriﬁ  cation of plasmid 
PDC312/oriP.luc
Double stranded plasmid DNA (pDNA) PDC312/oriP.luc 
(6 kb) expressing ﬁ  reﬂ  y luciferase (luc) under control of 
the oriP promoter was prepared by ligating the SalI/BamHI 
fragment, containing the oriP.luc cassette, isolated from pΔ 
E1sp1A/oriP.luc as described by Li et al (2002) with PDC312 
cut with the same enzymes. The plasmid was transformed into 
Escherichia coli DH5-a competent cells and puriﬁ  ed using 
a QIAGEN plasmid Mega kit. The DNA concentration and 
purity of the pDNA was assessed by measurement of the UV 
absorption at 260 and 280 nm.
Preparation and puriﬁ  cation 
of Adenovirus
Adenovirus vectors expressing luc under the control of a 
cytomegalovirus (CMV) promoter were ampliﬁ  ed in 293 
cells using established methods (Graham and Eb 1973), and 
puriﬁ  ed from cell lysates by banding twice on CsCl gradients. 
Puriﬁ  ed virus was then desalted overnight in 1:1000 parts 
by volume virus solution to Tris-HCl pH 8.0 buffer. Viral 
concentrations and purity were determined by the absorbance 
at 260 and 280 nm. The concentration of viral particles was 
calculated from the optical density at 260 nm (OD260), using 
the formula 1 OD260 = 1.1 × 1012 particles/ml as derived by 
Maizel et al (1968).
Preparation and characterization 
of pDNA polyelectrolyte complexes 
(PECs) and polymer-modiﬁ  ed adenovirus
PECs were prepared by the addition of aliquots of polymer 
stock solution (200 μg/mL in PBS) to pDNA (2 μg) to give 
the desired molar ratio of nitrogen atoms in the polymers to 
phosphorous atoms in the DNA (N:P). The N:P ratio was 
calculated from the equation:
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w
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:
/
/
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where fDMAEM is the weight fraction of DMAEM in the copo-
lymer, wpol is the weight of the copolymer, wDNA is the weight 
of pDNA, and the constants 157 and 325 represent the weight 
of DMAEM and DNA per nitrogen and phosphorous atom, 
respectively.
The total volume of solution was adjusted to 400 μl 
with PBS and vortexed for several seconds. The quantity of 
reagents was scaled up when necessary. Complex formation 
was carried out for 30 min at room temperature with gentle 
mixing using a hematological mixer. PECs used in trans-
fection experiments and for complexation with Ad5 were 
prepared in the same manner except that either α-MEM or 
RPMI-1640 was used in place of PBS.
Type I complexes between cationic polymers and Ad5 
particles were prepared by mixing stock polymer solutions in 
either α-MEM (CNE-1 cell infection) or RPMI-1640 (C666-1 
cell infection, with Ad5 dilutions at the desired ratio of poly-
mer to virus (typically 100 to 1000 polymer molecules/Ad5 
particle) and MOI (see Figure legends). Type II complexes 
were prepared by mixing PECs as described above with 
Ad5 dilutions.
Dynamic light scattering and zeta-
potential analysis of PECs
The volume–average particle size and size distribution of 
freshly prepared PECs of different N:P ratios in deionized 
water at 25 °C was measured using a NICOMP 380ZLS 
dual zeta/dynamic light scattering instrument equipped with 
a 10 mW, 632.5 nm laser in particle sizing mode. For zeta-
potential measurements, the NICOMP 380ZLS was switched 
to zeta-mode. All particle size and zeta-measurements were 
run in triplicate using 5 iterative cycles per sample. Prior to 
measurements, the NICOMP 380ZLS was calibrated using 
polystyrene latex particles (Polysicences Inc.) of known 
hydrodynamic size and surface charge.
Circular dichroism spectroscopy
Complexation of polymers with Ad5 and pDNA was exam-
ined by circular dichroism (CD) spectroscopy. PECs and 
polymer-modiﬁ  ed Ad5 were prepared as described earlier. 
CD spectra of pDNA, Ad5 and PEC and Ad5 complexes 
were recorded at 20 ºC in a 1 mm path length cuvette using 
an AVIV model 62A DS spectropolarimeter (Lakewood, NJ). 
The integration time was 1s and the slit width 2 nm.
Ethidium bromide displacement assay
The ethidium bromide assay was carried out to probe the 
association of polymers with pDNA. A 200 μL aliquot of International Journal of Nanomedicine 2007:2(3) 465
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50 μg/mL pDNA in PBS solution was diluted to 2 mL vol-
ume in a 1 cm cuvette. A 1 μL aliquot of a 400 μg/mL EtBr 
solution was introduced to the pDNA and mixed by gentle 
inversion. The fluorescence emission was recorded (λex = 
512 nm, λem = 600 nm, slit width ex/em = 5 nm/5 nm) on 
a Spex FluoroMax-3 fluorometer. A 5 mg/mL polymer 
solution was titrated into the pDNA/EtBr solution and 
the fluorescence emission monitored. The relative fluo-
rescence was calculated from the ratio of the observed 
fluorescence in presence of polymer relative to that in 
its absence, correcting for EtBr fluorescence according 
to the relation:
 %  Frel = (Fobs – FEtBr/FDNA-EtBr – FEtBr) × 100% 
where F is the ﬂ  uorescence emission intensity
Gel retardation assay
The gel retardation assay was used to evaluate that binding 
of the polycation to pDNA was the result of condensation. 
PECs incorporating 1 μg of pDNA were formed by mixing 
pDNA stock solution with aliquots of polymer stock solu-
tions (100 μg/ml in PBS). The total volume was adjusted to 
200 μl with PBS and complexation was carried out for 1 h 
at 25 °C. The PEC solution (25 μl) was run on a 0.7 wt.% 
agarose gel (100 V) in 1 × TAE (40 mM Tris-acetate and 
1 mM EDTA, pH 8.3 ) buffer. DNA bands were visualized 
by ethidium bromide staining.
In vitro transfection of CNE-1 and 
C666-1 NPC cells by PECs and polymer-
modiﬁ  ed Ad5
CNE-1 and C666-1 cells were seeded in a 24-well culture 
plate at 1 × 105 and 2 × 105 cells/well, respectively. For 
infection tests, the growth media were removed and the 
cells rinsed with PBS. A 200 μL aliquot of the Ad5 or 
polymer-modiﬁ  ed Ad5 vector in 2% heat-inactivated FBS 
media was introduced to the cells, typically at a multiplic-
ity of infection [MOI] = 50 and incubated for 1 h at 37 °C 
(5% CO2). The cells were washed 3 times with 200 μL of 
PBS, followed by addition of a fresh medium containing 
10% FBS. The cells were incubated for 24 h to allow for 
luciferase expression. The medium was then removed and 
the expressed luciferase was isolated according to the pro-
tocol supplied with the Dual-Light® Reporter Gene Assay 
System (Tropix, Applied Biosystems, Foster City, CA). All 
samples were run in triplicate using a ThermoLabsystems 
Luminoskan Ascent luminometer (Thermo Electron Corp., 
Waltham, MA, USA) for chemiluminescent detection.
Assay of cellular toxicity of NIPAM/
DMAEM polymers
CNE-1 cells were seeded in 96-well culture plates at 2 × 104 
cells/well in α-MEM. The medium was removed from plated 
cells and replaced with various concentrations of polymer 
(0.25–10 mg/ml) in serum-free α-MEM for 1 h at 37 °C 
under 5% CO2. The polymer solutions were then removed 
and replaced with α-MEM plus 10% FBS. The cells were 
allowed to proliferate for various time points (ie, 8–48 h) 
prior to the addition of 100 μL of MTT reagent (α-MEM, 
2% FBS). After 3 h incubation in presence of MTT reagent, 
175 μL of 0.1% HCl in isopropyl alcohol was added to each 
well and pipette tip aspirated. The absorbance of the solution 
was read at 570 nm using a BioRad 3550 microplate reader 
(BioRad, Hercules, CA). The cytotoxicity was calculated as 
the percentage of viable cells.
The experiment was repeated in triplicate using three 
different sets of cultured cells. Within each experiment, the 
values of six independent measurements (6 wells) at each 
concentration were obtained. The results are expressed as 
the mean ± S.D. from data obtained from the three separate 
measurements.
Transmission electron microscopy
A 50 μL aliquot containing 9 × 109 Ad5 particles in α-MEM 
was combined with a 50 μL aliquot of polymer solution at 
a polymer/Ad5 ratio of 100 polymer molecules/particle. 
The solution was gently aspirated and incubated at 37 °C 
for 15 min. 10 μL aliquots of polymer-modiﬁ  ed Ad5 ﬁ  xed 
with OsO4 and dispersed onto a Formvar-coated TEM grid, 
stained with lead citrate, and counterstained with 1% aqueous 
uranyl acetate for 30s. The solution was then removed and the 
grids dried in air. TEM images were captured using a Hitachi 
H-7000 (Tokyo, Japan) transmission electron microscope.
Results and discussion
Properties of NIPAM/DMAEM polymers
The chemical composition determined by feed and by 
1H NMR, molecular weight and pKa of the polymers are 
summarized in Table 1. It is seen that the NIPAM content 
determined by 1H NMR was slightly lower than the feed for 
most of the samples, probably because NIPAM is less reac-
tive in copolymerization than DMAEM (Brazel and Peppas 
1995; Lee et al 2003).  Additionally the copolymers of higher International Journal of Nanomedicine 2007:2(3) 466
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molecular weight, ie, ND15/85HMW, ND30/70HMW, and 
ND50/50HMW, consist of more NIPAM than the polymers 
of low molecular weight, ie, ND15/85LMW, ND30/70LMW, 
and ND50/50LMW. Since the low MW samples were synthe-
sized by addition of chain transfer agent, the higher NIPAM 
content in these samples may imply higher reactivity of 
the CTA with DMAEM monomer. The addition of a chain 
transfer agent lowers the molecular weight of the polymers 
dramatically from 87 × 104 – 289 × 104 dalton to 1.73 × 104 
– 2.82 × 104 dalton. The degree of MW reduction by use of 
CTA seems to depend on the NIPAM content in the feed. 
When the molar ratio of NIPAM to DMAEM is 0:100, the 
MW in the absence of CTA is 167-fold of that with the CTA. 
As the NIPAM/DMAEM ratio is increased to 50:50, the dif-
ference in the MW with or without the CTA is only 46-fold. 
This result may also suggest the effectiveness of CTA in the 
termination of DMAEM radicals.
The average pKa of the tertiary amine groups of DMAEM 
in the polymers was determined by titration with base. The 
titration curves of polymers (data not shown) were character-
ized by broad neutralization proﬁ  les suggesting a distribution 
of pKas within the polymer. Seemingly the pKa values were 
not dependent on the NIPAM content of the copolymers. The 
pKas of low molecular weight NIPAM/DMAEM polymers 
were slightly higher than the high MW analogs. It is possible 
that the amine groups in low MW samples are buried within 
the polymer chains and are, therefore, less accessible to the 
base during titration.
Properties of polymer-pDNA complexes
Figure 1 shows the intensity-average hydrodynamic diameter 
of PECs at different charge neutralization ratios for low (A) 
and high (B) MW polymers, respectively. The condensa-
tion process is characterized by a sharp rise in the diameter 
of the PECs followed by a dramatic decrease in diameter 
that reaches a minimum as the fully condensed state is ap-
proached. The diameter of condensed PECs ranged between 
115 and 187 nm for all polymers.
The ζ-potential of PECs was measured and plotted 
in Figure 2 as a function of N:P ratio for low MW (A) 
and high MW polymers (B). It is shown that the initially 
negative charges of PECs increase rapidly with increasing 
N:P ratio and above the point of zero charge (PZC) the 
PECs become positively charged. The N:P ratio at the 
PZC, listed in Table 2, increases with increasing NIPAM 
content and decreasing molecular weight, suggesting 
that large macromolecular chains and NIPAM units may 
screen the exposure of the cationic charges to DNA, and 
thus higher N:P ratios are required for neutralizing the 
negative charges. The final ζ-potential of the PECs, ζﬁ  nal, 
summarized in Table 2 which were found from the plateau 
of the curves in Figure 2 and, increases with decreasing 
NIPAM content and increasing MW of the polymers. 
The composition dependence of ζﬁ  nal seems to be more 
marked in high MW samples (Figure 2B) than in low MW 
samples (Figure 2A). As the positive charges stem from 
the cationic polymers, the higher the DMAEM content, 
the higher the positive charges.
Notably, ζmax decreased with increasing NIPAM content 
and decreasing molecular weight, suggesting that the number 
of incorporated polymer molecules in the PEC structure does 
not vary appreciably. These ﬁ  ndings are consistent with the 
DLS data showing that higher molecular weight, DMAEM-
enriched polymers are more effective as condensing agent 
than their lower molecular weight copolymer analogs incor-
porating NIPAM.
The N:P ratio required for condensation (N:P ﬁ  nal, 
Table 2) increased with decreasing DMAEM content of 
the polymers This suggests that the primary mechanism for 
condensation is the binding of negative charge on the pDNA 
by positively charged DMAEM. Hydrophilic polymers such 
as PEG are known to imbibe water molecules and promote 
pDNA condensation by an osmotic mechanism (Kombrabail 
et al 2005). However, in the NIPAM/DMAEM system, no 
such effect was observed.
To further probe the nature of NIPAM/DMAEM binding 
of pDNA, EtBr intercalation and agarose gel electrophoresis 
assays were performed. These methods complement the light 
scattering and electrophoresis techniques by providing a 
measure of the strength of polycation binding to pDNA and 
may be important indicators of the likelihood of endosomal 
Table 1 Properties of NIPAM/DMAEM copolymers
Polymer1,2  % mol   % mol   Mv pKa
  NIPAM  NIPAM  (Da x 10-4) 
 ( 1H NMR)  (feed)   
ND0/100LMW 0  0  1.73  7.5
ND0/100HMW 0  0  289  7.0
ND15/85LMW 10.9  15.0  3.26  7.5
ND15/85HMW 13.1  15.0  197  7.0
ND30/70LMW 22.8  30.0  2.82  7.5
ND30/70HMW 25.8  30.0  193  7.0
ND50/50LMW 52.0  50.0  1.89  7.6
ND50/50HMW 56.6  50.0  87.4  7.1
1Copolymer nomenclature: N – NIPAM, D – DMAEM, %mol NIPAM/%mol DMAEM 
in polymerization feed, LMW – low molecular weight, HMW – high molecular 
weight.
2LMW samples incorporate 10% mol 2-mercaptoethanol relative to total monomer 
content in polymerization feed.International Journal of Nanomedicine 2007:2(3) 467
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escape and, hence, transfection efﬁ  ciency. In the absence of 
NIPAM/DMAEM, EtBr intercalates into pDNA yielding a 
ﬂ  uorescent complex that emits at ~600 nm. Using this value 
as the reference, the relative ﬂ  uorescence intensity of the 
PECs at various N:P ratios are plotted in Figures 3A and 3B 
for low and high MW samples respectively. The N:P values 
required to reduce the ﬂ  uorescence intensity by 50%, N:P50, 
were found from the plot and are listed in Table 2. There is 
a sharp decrease in ﬂ  uorescence intensity as the pDNA/EtBr 
complex is titrated. As shown in Table 2, N:P50 values were 
markedly lower than the N:P values for neutralizing the nega-
tive charges as determined by ζ-potential analysis. PDMAEM 
readily displaced EtBr with nearly the same efﬁ  ciency on a 
per charge basis as PEI. NIPAM/DMAEM copolymers also 
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readily displaced EtBr in a composition dependent manner. 
At low levels of NIPAM, displacement occurred nearly as 
efﬁ  ciently as with the DMAEM homopolymer. A pronounced 
decrease in the ability of the polymers to displace EtBr was 
observed in samples exceeding 50% mol NIPAM content. 
Notably, the effect of the polymer molecular weight on 
binding was not as pronounced as would have been expected 
from the light scattering results. This suggests that low MW 
NIPAM/DMAEM polymers are able to bind pDNA nearly 
as efﬁ  ciently as the high MW analogs, but are not as effec-
tive at promoting the structural rearrangement of pDNA that 
leads to its compaction.
The migration through agarose gels of PEC-complexed 
DNA prepared from PEI and PLL were compared with 
the high molecular weight PDMAEM polymer (ND0/
100HMW) (Figure 4). In the absence of polycation, two 
bands attributable to circular (upper band) and supercoiled 
(lower band) pDNA were observed (lane 2). When pDNA 
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was complexed with the polycations at N:P ratios above 2:1, 
complete retardation of pDNA migration was observed for 
all of the polymers tested (lanes 3–12). This indicates that 
PDMAEM binds pDNA as effectively as other more highly 
charged polycations, when normalized for charge content. 
Figure 5 shows the effects of NIPAM/DMAEM copolymer 
composition and N:P ratio on the binding of pDNA. There 
was clear migration of pDNA in all NIPAM/DMAEM 
samples complexed at N:P ratios of 0.2:1 and 1:1 (lanes 
4–12). However, at N:P of 2:1, the migration of pDNA was 
retarded in all samples up to 30 mol% NIPAM (lanes 6, 9 
and 12). It is interesting to note that only the ND15/85LMW 
PEC (lane 9) was able to fully retard DNA migration as 
evidenced by the lack of band in the gel center.
Investigation of pNIPAM/DMAEM and 
PEC–DNA complexation with adenovirus
CD spectroscopy can be used as a tool to probe changes in 
secondary and higher order structural features of nucleic 
acids and proteins in solution. Here, this technique was used 
to investigate the interaction of NIPAM/DMAEM polymers 
pDNA and in Type I and Type II modiﬁ  ed adenovirus vectors. 
Figure 6 shows that the CD spectrum of PDMAEM PECs is 
markedly different from that of the pDNA. The spectrum of 
ND0/100HMW at N:P = 5:1 exhibited diminished intensity 
and characteristic red shifts of the 210, 220, 245 and 275 nm 
bands of native pDNA. PECs formed from the copolymer 
containing 50% mol NIPAM (ND50/50HMW) at the same 
N:P ratio (5:1) (Figure 7), exhibited less dramatic changes in 
spectral bands suggesting reduced levels of interaction between 
NIPAM-containing polymers with DNA. Increasing the N:P 
ratio to 10:1 induces a greater change in pDNA structure as 
evidenced by the reduced band intensity. There is no signiﬁ  cant 
change in the CD spectrum of the ND50/50HMW PECs, when 
the temperature of the suspending medium was increased to 
40 °C (above the LCST of NIPAM). This suggests that the 
thermo-responsive nature of NIPAM segments do not affect 
pDNA complexation in the vicinity of physiologically attain-
able temperatures. Twaites et al. observed a small temperature 
dependent decrease in the particle size of PECs prepared from 
NIPAM/DMAEM-co-hexylacrylate terpolymers at 45 °C, that 
was attributed to local coil-globule NIPAM segment collapse 
(Twaites 2004). However, our CD data suggests that, at least in 
the case of NIPAM/DMAEM copolymers, the interaction with 
pDNA is unaffected by temperature, in the 25–40 °C range. 
It is possible that changes in the size of the hydration shell of 
these PECs may account for the small decrease in their particle 
size at elevated temperatures. The LCST of NIPAM/DMAEM 
copolymers studied here were in excess of 50 °C at pH 7.4 (data 
not shown), indicating that positively charged amino groups of 
DMAEM prevent collapse of NIPAM chains, thereby, further 
corroborating the CD ﬁ  ndings.
CD spectroscopy was used to probe the changes in 
structural features of Ad5 capsid proteins resulting from 
complexation with NIPAM/DMAEM polymers and PECs. 
As illustrated in Figure 8, the CD spectrum of Ad5 reveals 
bands in the region 210–230 nm, characteristic of an α-
helix protein conformation. Abolition of α-helix spectral 
fine structure of this band was observed when Ad5 was 
used to form a Type I complex with ND0/100HMW. Even 
more pronounced changes are observed in the α-helix 
band of a Type II complex with ND0/100HMW and Ad5. 
As is seen in Figure 8 by comparing the features of the 
pDNA and PEC spectra with those of Ad5, it is doubtful 
that these spectral changes result from a superposition 
of Ad5 and pDNA spectral features given the constancy 
of intensity in the region above 240 nm. Therefore, the 
binding of polymers and PECs onto the Ad5 capsid can 
be characterized spectrophotometrically by following 
changes in the spectral characteristics of viral proteins. 
Indeed, one may speculate as to the nature of the interac-
tion between PDMAEM coatings and viral capsid proteins 
responsible for cell entry. Mathias et al have reported a 
conserved Arg-Gly-Asp (RGD) motif in the sequenced 
penton bases of several adenovirus serotypes that were 
purported to play a role in viral cell entry via αv integrins 
(Mathias et al 1994). The predicted secondary structure 
of the RGD domain of the adenovirus penton base was 
that of a helix-turn-helix with the RGD domain at the 
apex of the α-helices. Thus, the CD analysis suggests 
that PDMAEM and PDMAEM PECs coatings complex 
Table 2 Properties of NIPAM/DMAEM PECs.
Polymer DLS  Zeta-Potential  EtBr  Intercalation
 D I, min  ζﬁ  nal N:PPZC N:P50
 (nm)  (mV)   
PEI  115 ± 26  25.3 ± 1.0  2.5  0.5
ND0/100LMW  131 ± 30  14.7 ± 0.8  3.9  0.6
ND0/100HMW  133 ± 36  20.6 ± 0.8  3.0  0.6
ND15/85LMW  140 ± 30  13.6 ± 1.2  5.6  0.8
ND15/85HMW  125 ± 17  16.9 ± 1.5  3.5  0.9
ND30/70LMW  140 ± 20  9.2 ± 0.5  7.4  1.7
ND30/70HMW  123 ± 18  12.2 ± 0.8  5.5  1.6
ND50/50LMW  187 ± 30  5.9 ± 1.1  9.6  4.0
ND50/50HMW  146 ± 23  8.8 ± 0.9  7.3  4.2
The diameter, DI, min, and the zeta-potential are presented as mean ±SD (n = 3).International Journal of Nanomedicine 2007:2(3) 470
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with amino acids in the vicinity of Ad5 binding domains. 
This finding may have implications in terms of the im-
munologic and internalization role of polymers in Type 
I and Type II Ad5 vector cell entry.
The binding of NIPAM/DMAEM polymers and PECs 
to the Ad5 capsid was visualized by TEM. Figure 9 shows 
low- and high-resolution images of Ad5 and Type II Ad5. 
The Type II Ad5 had to be diluted extensively to reduce the 
propensity of viral precipitation. The micrograph shows that 
binding of PECs does not result in complete coating of the 
viral capsid. A larger quantity of PEC may be necessary for 
complete capsid coating.
The results of MTT assay of cytotoxicity of the 
NIPAM/DMAEM polymers towards CNE-1 cell lines are 
shown in Figure 10. The toxicity of the polymers increased with 
molecular weight and the DMAEM content. The PDMAEM 
homopolymer was fairly toxic with an ID50 around 0.2 mg/mL. 
Most samples were characterized by an abrupt cessation or level-
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ing off of toxicity above a threshold value which increased with 
NIPAM content and decreasing molecular weight.
Effect of polymers on the tranduction/
transfection efﬁ  ciency
Figure 11 shows the results of transfection of C666-1 NPC 
cells by NIPAM/DMAEM PECs. The level of expression of 
ﬁ  reﬂ  y luciferase provides an indication of the efﬁ  ciency 
of transfection by the PECs. In each case, high molecular 
weight NIPAM/DMAEM polymers were on the order 
of 5-fold more efﬁ  cient at expressing the reporter gene 
than were the low molecular weight analogs. Transfection 
levels decreased markedly with increasing NIPAM content 
in the polymer. Notably, the transfection with PDMAEM 
homopolymer PECs was as effective as or better than PECs 
prepared from the established transfectant, PEI. The drop off 
in transfection levels between PDMAEM homopolymers and 
ND0/50 polymers was in excess of 90%. Since, the NIPAM-
bearing polymers were effective at condensing pDNA, elu-
cidation of the origin of this dramatic change in transfection 
efﬁ  ciency may require further studies on the compositional 
dependence of PECs for endosomal escape and protection of 
pDNA from nucleases.
In Figure 12, the transduction efﬁ  ciencies of CNE-1 
NPC cells by type I polymer-modiﬁ  ed Ad5 vectors are 
compared. The efﬁ  ciencies of the highly branched and 
highly charged PEI-modiﬁ  ed vectors were compared with 
those derived from PDMAEM and NIPAM/DMAEM copo-
lymers. PEI-modiﬁ  ed Ad5s transduced CNE-1 cells more 
efﬁ  ciently than the untreated Ad5s at the same infectivity 
ratio. Moreover, increasing the quantity of PEI coating the 
virus by 100% produced a concomitant increase in the ex-
pression level. The PDMAEM homopolymers that were used 
to modify the Ad5, were almost as effective at promoting 
reporting gene expression as the PEI-modiﬁ  ed Ad5 vectors. 
For the PDMAEM and NIPAM/DMAEM polymers, the 
Figure 10 Toxicity of NIPAM/DMAEM copolymers towards CNE-1 nasopharyngeal carcinoma cells; A) ND0/100; B) ND15/85; C) ND30/70; D) ND50/50 (n = 3).
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Figure 12  Luciferase expression in CNE-1 transfected with Type I Ad5-CMV/luc. Numbers in parentheses denote (MOI/ng polymer) in Ad5 suspension (n = 3).
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Figure 13  Luciferase expression in C666-1 transfected with Type II Ad5-CMV/Luc complexes at MOI = 10 pfu, N:P ratio of PEC in parentheses.  + denotes active expres-
sion via plasmid or adenovirus, –denotes UV knockout; the ﬁ  rst sign refers to plasmid, the second to Ad5 (n = 3). 
HMW samples yielded slightly higher levels of expression 
than the LMW samples. Interestingly, the expression levels of 
ND15/85 modiﬁ  ed Ad5s were only slightly lower than those 
of the PDMAEM homopolymers and essentially independent 
of molecular weight.
Figure 13 shows the results of tests of transfection and 
transduction efﬁ  ciency of Type II polymer-modiﬁ  ed Ad5 vec-
tors. The Type II vectors utilizing both functionally expressive 
pDNA and Ad5 (denoted +/+) exhibited the highest transgene 
expression levels. The vectors that incorporated the PECs that 
exhibited the highest transfection efﬁ  ciency (ND0/100HMW) 
also had the highest expression. Expression levels decreased 
when the NIPAM content in the PEC of the Type II vector 
was increased. When the Ad5 was functionally knocked out 
by irradiation, expression of the Type II vector should be a 
consequence of the condensed pDNA alone. The dark shaded 
bars in Figure 13, in most cases indicate that 50% or more of 
the total transgene expression resulted from the pDNA. It is 
difﬁ  cult to ascertain whether this is caused by interference 
of transduction of Ad5 by PECs or simply due to the greater 
accessibility of the PECs to the cell surface thereby facilitating 
more facile cellular entry.
Conclusion
Copolymers of NIPAM/DMAEM were tested as components 
of non-viral transfectants and as modiﬁ  ers of adenoviral vec-
tors for gene delivery. As transfectants, NIPAM/DMAEM 
copolymers were shown to effectively condense pDNA across 
a broad range of molecular weights and compositions to sizes 
suitable for gene delivery application. CD spectra revealed 
small red shifts and diminution of spectral band intensity of 
pDNA indicating structural changes upon complexation with 
cationic polymers. PECs prepared from copolymers of higher 
MW and higher DMAEM content were more efﬁ  cient transfec-
tants of nasopharyngeal cell lines. This was offset by a mod-
est increase in toxicity of these polymers. NIPAM/DMAEM 
polymers effectively modulated gene expression observed by 
adenovirus vectors both in Type I and Type II polymer-modi-
ﬁ  ed Ad5 vector systems. This suggests that these materials 
can be used to enhance gene expression either by mediating 
infection of adenovirus expressing systems or using pDNA 
plus the adenovirus as a carrier. Future studies will investigate 
the potential of these polymers to facilitate hyperthermic lo-
calization of the PECs and the polymer-modiﬁ  ed Ad5 vectors 
and assess their biodistribution and RES avoidance.International Journal of Nanomedicine 2007:2(3) 477
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